Anyone interested in NeoGenomics, Inc. (NASDAQ:NEO) should probably be aware that the Senior VP & Chief Accounting Officer, Gregory Aunan, recently divested US$321k worth of shares in the company, at an average price of US$16.07 each. In particular, we note that the sale equated to a 80% reduction in their position size, which doesn’t exactly…
